Most lately, it has been discovered that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts as being a scavenger and doesn't activate a 2nd me